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Abstract
Background: Acute kidney injury (AKI) is a serious complication of critical illness with both attributed morbidity and
mortality at short-term and long-term. The incidence of AKI reported in critically ill patients varies substantially with the
population evaluated and the definitions used. We aimed to assess which of the AKI definitions (RIFLE, AKIN or KDIGO)
with or without urine output criteria recognizes AKI most frequently and quickest. Additionally, we conducted a review
on the comparison of incidence proportions of varying AKI definitions in populations of critically ill patients.
Methods: We included all patients with index admissions to our intensive care unit (ICU) from January 1st, 2014 until June
11th, 2014 to determine the incidence and onset of AKI by RIFLE, AKIN and KDIGO during the first 7 days of ICU admission.
We conducted a sensitive search using PubMed evaluating the comparison of RIFLE, AKIN and KDIGO in critically ill patients
Results: AKI incidence proportions were 15, 21 and 20% respectively using serum creatinine criteria of RIFLE, AKIN and
KDIGO. Adding urine output criteria increased AKI incidence proportions to 35, 38 and 38% using RIFLE, AKIN and KDIGO
definitions. Urine output criteria detected AKI in patients without AKI at ICU admission in a median of 13 h (IQR 7–22 h;
using RIFLE definition) after admission compared to a median of 24 h using serum creatinine criteria (IQR24-48 h). In the
literature a large heterogeneity exists in patients included, AKI definition used, reference or baseline serum creatinine used,
and whether urine output in the staging of AKI is used.
Conclusion: AKIN and KDIGO criteria detect more patients with AKI compared to RIFLE criteria. Addition of urine output
criteria detect patients with AKI 11 h earlier than serum creatinine criteria and may double AKI incidences in critically ill
patients. This could explain the large heterogeneity observed in literature.
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Background
Acute kidney injury (AKI) is a serious complication of
critical illness with both attributed morbidity and mor-
tality at short and long-term [1–7]. The incidence of
AKI reported in critically ill patients varies substantially
[4, 8]. Before 2004 the diagnosis of AKI was based on
urine output and markers of decreased urinary waste
secretion i.e., serum urea and creatinine as markers of a
decreased glomerular filtration rate (GFR), but differed
per study. In 2004 an attempt was made to standardize
outcomes of studies by unifying the definition of AKI
using the Risk, Injury, Failure, Loss and End-stage
(RIFLE) definitions [9]. In 2007 adjustments resulted in
the Acute Kidney Injury Network (AKIN) definition,
driven by observations that minor increases in serum
creatinine over a shorter time period are also associated
with adverse effects. The current definition made by
Kidney Disease Improving Global Outcomes (KDIGO) is
similar to the AKIN definition but the time frame is ex-
tended from 48 h to 7 days [10, 11]. Serum creatinine is
considered an inferior marker of kidney function during
critical illness, as the rise in serum creatinine is com-
monly delayed after kidney function decline [12, 13].
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Adding urine output criteria to creatinine levels in-
creases AKI incidences compared to criteria using serum
creatinine levels only [14–18]. However, many studies
dismiss hourly urine output data as this data is often
hampered by frequent missing values. Consequently,
studies may report AKI using three different definitions,
all with or without urine output criteria. Comparison of
published studies is hampered by this dissimilarity.
Objective
We aimed to assess the difference in AKI incidence
using the three definitions, with and without urine out-
put criteria, and to assess which AKI definition recog-
nizes AKI first. Second, we aimed to assess differences
in patient characteristics in patients with AKI according
to the three definitions. Additionally, we conducted a
review on incidence proportions of AKI varying with
definitions in critically ill patients.
Methods
I Cohort study
We included all patients with index admissions to our
intensive care unit (ICU) from January 1st, 2014 until
June 11th, 2014. Informed consent was waived by the in-
stitutional Review Board of our hospital because the
study had an observational design and all data were de-
identified (METc University Medical Center Groningen,
Medical Ethical Committee, chairman Prof. dr. W. A.
Kamps,reference number 2013–174).
Data collection
Baseline data were recorded for all patients, including age,
sex, Body Mass Index (BMI), admission category and type
(medical and surgical; scheduled and emergency), the
presence of diabetes mellitus, and chronic kidney disease.
We recorded mortality and length of stay (ICU and
hospital). Serum creatinine was measured each day and
urinary output was recorded hourly. Reference creatinine
was based on the calculated ideal serum creatinine assum-
ing a clearance of 75 ml/min/1.73 m2 using the Modifica-
tion of Diet in Renal Disease (MDRD) formula. Missing
hourly urine output data was imputed based on averages
using the first known value over the missing hours. AKI
timing and incidence was estimated up to the first seven
ICU admission days.
Definitions of AKI
AKI during the first 7 days of ICU admission was defined
according to the RIFLE, AKIN and KDIGO definitions. Using
serum creatinine with and without urine output criteria. The
definitions are described in Additional file 1: Table S1.
Comparison of AKI definitions
RIFLE uses Glomerular Filtration Rate (GFR) criteria in
addition to serum creatinine and urine output criteria.
GFR criteria were abandoned in the AKIN and KDIGO
definitions. The Risk, Injury and Failure categories of the
RIFLE definition were replaced by AKIN and KDIGO
stages 1, 2 and 3. In AKIN stage 1 an absolute rise in
serum creatinine of more than 26.4 μmol/l was added to
the relative increase of 150–200% in serum creatinine
compared to baseline. This increase in serum creatinine
of more than 26.4 μmol/l in AKIN stage 1 was replaced
by an absolute rise in serum creatinine of more than
26.5 μmol/l in stage 1 of the KDIGO definition. Both in
the RIFLE and KDIGO definitions the increase in cre-
atinine is defined to occur within 7 days, which contrasts
with the 48 h used in the AKIN definition.
In stage 3 of the AKIN and KDIGO definitions the
need for renal replacement therapy (RRT) was added.
The categories Loss and End Stage Kidney disease or
equivalent (outcome) categories from the RIFLE defin-
ition were removed from the AKIN and KDIGO defini-
tions. Urine output criteria are similar in RIFLE, AKIN
and KDIGO definitions.
Statistical analyses
Incidence proportions of AKI were based on definitions of
AKI criteria during the first week of ICU admission. Base-
line characteristics were reported by proportions and
means (with standard deviations) or medians (with inter
quartile ranges) according to normality or skewed distri-
butions. Normality was tested using the Kolmogorov-
Smirnov test. Data were statistically tested using students
t-test, MannWhitney U test or Chi square test when ap-
propriate. In case of differences in incidences between the
three AKI definitions a MANOVA post hoc analysis with
the Least Significance Difference (LSD) of patient groups
was performed. SPSS (IBM 2013, version 22) was used.
II Review
Search
We conducted a sensitive search in PubMed concerning
the comparison of RIFLE, AKIN and KDIGO in critically ill
patients (see Additional file 1 for search terms). Only stud-
ies with adult patients that compared incidence proportions




The study was performed in a 42-bed critical care depart-
ment in a tertiary referral hospital with 3561 admissions in
2014. In the study period 1376 patients were admitted with
a total of 5734 observation days. 172 patients were
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readmitted once or more during the study period. A total of
221 readmissions were excluded for further analysis (Fig. 1).
The mean age was 60 years and 63% of patients were
male. A surgical intervention preceded admission in 66%
of the patients of which 80% were planned. A total of
221 patients (16%) had diabetes and 58 patients (4.2%)
had chronic kidney disease (CKD) including 24 patients
(1.7%) on chronic renal replacement therapy (RRT). ICU
mortality was 5.6% and the median length of ICU stay
was 2 days (IQR 2–3) (Table 1).
Total prevalence of AKI varies with the definition
A total of 107 patients (7.8%) met the criteria for AKI
using the RIFLE definition based on serum creatinine
and 384 patients (28%) met the criteria based on urine
output during the first week of ICU admission. The
combination of serum creatinine and urine output using
the RIFLE definition resulted in 475 patients (35%) with
AKI. For AKIN 160 patients (12%) met the criteria for
AKI based on serum creatinine and 384 patients (28%)
met the criteria based on urine output during the first
week of ICU admission. The combination of serum
creatinine and urine output using the AKIN definition
resulted in 524 patients (38%) with AKI. Using the
KDIGO definition 147 patients (11%) met the criteria
for AKI based on serum creatinine and 384 patients
(28%) met the criteria based on urine output during the
first week of admission. The combination of serum
creatinine and urine output using the KDIGO definition
resulted in 517 patients (38%) with AKI (Table 1, Fig. 1
and Additional file 1: Table S2).
The patients only fulfilling AKI definitions based on
urine output criteria more frequently had diabetes melli-
tus and were predominantly admitted after scheduled
surgery compared to patients who fulfilled AKI criteria
based on their serum creatinine (Table 2).
Eighty four patients were detected on admission as hav-
ing AKI using the serum creatinine criteria of the AKIN
and KDIGO definitions who remained undetected using
the RIFLE definition. Fourteen patients were recognized
as having AKI only when using the AKIN definition
(Table 3). One patient was detected as having AKI only
with the KDIGO definition. (not included in Table 3).
These patients differed in age, severity of illness, admis-
sion type, comorbidity, ICU length of stay and mortality.
Patients only detected by AKIN and KDIGO were less ill
and were admitted more frequently after scheduled sur-
gery compared to the other groups (Table 3).
Fig. 1 Flowchart with numbers of patients included in the study with AKI at admission and AKI during the first week of admission according to
the RIFLE, AKIN and KDIGO definitions. Left column: patients screened for inclusion. Middle column: patients with AKI at admission according to
the three definitions and severity. Right column: numbers of patients with AKI during the first week of ICU admission according to the three
definitions, severity and with or without urine output criteria. Grouped by patients with AKI at admission and patients without AKI at admission;
RIFLE: ‘risk’, ‘injury’, ‘failure’, ‘loss’ and ‘end-stage’ definition. AKIN: acute kidney injury network definition. KDIGO: kidney disease improving global
outcome definition. SCr = serum creatinine, UO = urine output
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Incidence of AKI varies with the definition
Of all patients who had AKI during the first week of
ICU admission 142 patients (10%) were admitted with
AKI according to the RIFLE definition, 200 patients
(15%) according to the AKIN definition and 198 patients
(14%) according to the KDIGO definition (Fig. 1). Of all
patients without AKI according to the RIFLE definition
at ICU entry 68 patients (4.9%) developed AKI based on
RIFLE serum creatinine criteria. When the AKIN defin-
ition was used 94 patients (6.8%) developed AKI and
when the KDIGO definition was used 83 patients (6.0%)
developed AKI (Fig. 1 and Additional file 1: Table S2).
The severity of AKI during the first week of ICU ad-
mission varied with the definitions used.
RIFLE stage ‘risk’ occurred in 67 patients (4.9%) using
the creatinine criteria solely and in 230 patients (17%)
when combined with the urine output criteria. For RI-
FLE stage ‘injury’ this was 62 patients (4.5%) and 144 pa-
tients (10%), respectively, and for RIFLE stage ‘failure’ 81
patients (5.9%) and 86 patients (6.3%), respectively.
Incidence of AKIN stage 1 occurred in 137 patients
(10%) based on the creatinine criteria and in 272 patients
(20%) when combined with the urine output criteria. For
AKIN stage 2 this was 60 patients (4.4%) and 126 patients
(9.2%), respectively, and for AKIN stage 3 this was 97 pa-
tients (7.0%) and 108 patients (7.9%), respectively.
KDIGO stage 1 occurred in 127 patients (9.2%) based
on the creatinine criteria and in 271 patients (20%) when
combined with the urine output criteria. For KDIGO
stage 2 this was 50 patients (3.6%) and 119 patients
(8.6%), respectively, and for KDIGO stage 3 this was 104
patients (7.6%) and 106 patients (7.7%) respectively
(Additional file 1: Table S2).
Timing of detection of AKI varying with definitions
For urine output criteria, the median time until detection
was 13 h with all three definitions (RIFLE IQR 7–22 h,
AKIN IQR 7–23 h, KDIGO IQR 7–23 h). Timing and in-
cidence of AKI based on serum creatinine criteria is com-
parable between RIFLE, AKIN and KDIGO in the first
48 h of admission (Additional file 1: Figure S1). AKI was
detected after a median of 24 h (IQR 24–48) using the
serum creatinine criteria for RIFLE, AKIN or KDIGO defi-
nitions (Fig. 2).
II Review
A total of 383 hits were screened and 24 papers that
compared RIFLE, AKIN and/or KDIGO definitions were
selected for inclusion (Additional file 1: Table S3). One
study was published as abstract only [19]. Fourteen stud-
ies evaluated incidences of AKI in critically ill patients
and found proportions varying from 34% to 81% using
RIFLE definition, from 29% to 77% using AKIN defin-
ition and from 38% to 51% using KDIGO definition.
AKI incidences in critically ill patients in prospective studies
Six studies used a prospective design to evaluate AKI inci-
dences based on two or more definitions. Two studies com-
pared all three AKI definitions RIFLE, AKIN and KDIGO
and two other studies compared two AKI definitions. All
studies excluded specific subgroups from their studies when
defining AKI incidences. Three studies used urine output
criteria in addition to creatinine for defining AKI.
Luo et al., evaluated AKI based on RIFLE, AKIN and
KDIGO in 3107 patients. This study excluded patients
who stayed in the ICU for less than 24 h and patients
Table 1 Basic patient characteristics
Characteristic of patients (N = 1376)
Age (years; mean (sd)) 60 (16)
Male sex (N (%)) 864 (62.8)
Body Mass Index (kg/m2, mean(sd)) 26 (5.2)
APACHE IV (mean(sd)) 52 (25)
Admission type
• Medical (N (%)) 461 (33.5)
• Surgical (N (%)) 914 (66.4)
◦ scheduled (N (%)) 727 (52.8)
◦ emergency (N (%)) 187 (13.6)
Co morbidity
• diabetes mellitus (N (%)) 221 (16.1)
• chronic kidney disease (N (%)) 58 (4.2)
• chronic dialysis (N (%)) 24 (1.7)
ICU LoS (days; median [IQR]) 2 [2.0–3.0]
ICU mortality (N (%)) 77 (5.6)
Hospital mortality (N (%)) 129 (9.4)
Serum creatinine at admission
(μmol/l; median [IQR]) (N = 1369)
73 [58–93]
Acute kidney injury in first 7 days of admission
• RIFLE (N (%)) 210 (15.2)
◦ With UO criteria (N (%))
• AKIN (N (%))
475 (34.5)
294 (21.4)
◦ With UO criteria (N (%)) 524 (38.1)
• KDIGO (N (%)) 281 (20.4)
◦ With UO criteria (N (%)) 517 (37.6)
• Urine output RIFLE (N (%)) 265 (19.3)
• Urine output AKIN (N (%)) 230 (16.7)
• Urine output KDIGO (N (%)) 236 (17.2)
Renal replacement therapy (N (%)) 62 (4.5)
IQR interquartile range
N number of patients
APACHE IV Acute Physiology and Chronic Health Evaluation IV
ICU intensive care unit
LoS length of stay
UO urine output
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with end stage kidney disease, patients on RRT and pa-
tients who had a renal transplant in the preceding
3 months. Baseline creatinine was based on the lowest
creatinine in the preceding 3 months, or the ideal
creatinine based on 75 ml/min/1.73 m2 using the
MDRD, or the lowest creatinine during ICU admission.
AKI severity was based on the highest classification
using both serum creatinine and urine output criteria,
measured either hourly or averaged over 6 h. AKI inci-
dences were 47%, 38%, and 51% using RIFLE, AKIN, and
KDIGO definitions, respectively [20].
The study of Levi et al., compared all three definitions
in 190 patients and excluded patients admitted for less
than 24 h and patients on RRT before admission. The au-
thors did not specify baseline creatinine and used average
urine output over 6 h. AKI incidences were 63% for all
three definitions. The distribution of AKI severity differed
between AKIN and KDIGO in stages 2 and 3 [21].
Reddy et al., compared AKI incidences using RIFLE
and AKIN definitions in 250 patients. All patients with a
preexisting renal disease were excluded. Baseline creatin-
ine was based on the lowest serum creatinine during
hospital or ICU admission or calculated based on a
MDRD of 75 ml/min/1.73 m2. AKI was based on both
creatinine and urine output criteria, but measurement of
urine output collection was not specified. The authors
found higher incidences of AKI using AKIN compared
to RIFLE (46% versus 34%) [22].
Wlodzimirow et al., compared incidences in AKI based
on RIFLE in 260 ICU patients admitted for at least 48 h
and excluded patients with known end stage renal disease.
The lowest value of serum creatinine in the preceding
6 months or the estimated serum creatinine based on the
MDRD assuming a clearance of 75 ml/min/1.73 m2 was
used as reference value. Urine output was measured
hourly. Incidences of AKI with and without urine output
criteria were 81% and 42%, respectively [15].
Macedo et al., compared incidence in AKI based on
AKIN in 75 patients and excluded patients with known
end stage renal disease or receiving RRT. The first
serum creatinine at ICU admission was used as refer-
ence creatinine and urine output was measured hourly.
The incidences of AKI according to the AKIN defini-
tions were 28%, 55% and 60% based on serum creatinine,
urine output, and a combination, respectively [16].
A multicenter study by Salgado et al., in 627 ICU patients
compared AKI incidences using RIFLE and AKIN defini-
tions with and without urine output criteria in patients
Table 2 Patient characteristics and outcome of patients grouped by AKI definition and on positive urine output criteria alone or
with serum creatinine criteria















Age (years; mean (sd)) 62 (15) 63 (15) 0.753 62 (15) 62 (15) 0.978 62 (15) 63 (14) 0.478
Male sex (N (%)) 173 (54) 34 (10) 0.185 149 (48) 45 (15) 0.182 153 (50) 41 (13) 0.265
Body Mass Index (kg/m2; mean (sd)) 27 (5) 26 (6) 0.184 27 (5.2) 26 (5.7) 0.051 27 (5.3) 26 (5.8) 0.118
APACHE IV score (mean (sd)) 54 (25) 75 (22) 0.000 52 (23) 72 (26) 0.000 52 (23) 74 (26) 0.000
Admission type
• medical (N (%)) 105 (32) 22 (6.7) 0.009 88 (28) 31 (10) 0.052 95 (31) 22 (7.1) 0.006
• surgical
◦ scheduled (N (%)) 124 (38) 21 (6.4) 112 (36) 30 (9.7) 112 (36) 30 (9.7)
◦ emergency (N (%)) 36 (11) 18 (5.5) 30 (9.7) 19 (6.1) 29 (9.4) 20 (6.5)
Co morbidity
• diabetes mellitus (N (%)) 47 (14) 11 (3.4) 1 40 (13) 12 (3.9) 0.729 41 (13) 11 (3.6) 0.857
• chronic kidney disease (N (%)) 3 (0.9) 2 (0.6) 0.236 2 (0.6) 3 (0.9) 0.110 2 (0.6) 3 0.085
• chronic dialysis (N (%)) 0 (0) 0 (0) na 0 (0) 0 (0) na 0 (0) (0.97) 0 (0) na
ICU Length of stay (days; median [IQR]) 3 [2–6] 6 [3–11] 0.000 3 [2–5] 6 [3–11] 0.000 3 [2–6] 5 [3–9.8] 0.000
ICU mortality (N (%)) 13 (4.0) 6 (1.8) 0.139 8 (2.6) 11 (3.5) 0.002 10 (3.2) 9 (2.9) 0.021
Hospital mortality (N (%)) 24 (7.4) 13 (4.0) 0.012 17 (5.5) 19 (6.1) 0.000 19 (6.2) 17 (5.5) 0.001
RIFLE ‘risk’, ‘injury’, ‘failure’, ‘loss’ and ‘end-stage’ definition
AKIN acute kidney injury network definition
KDIGO kidney disease improving global outcome definition
UO urine output. SCr: serum creatinine
N number of patients
P-value difference between patients with only urine output criteria positive and patients with both criteria positive
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admitted for at least 48 h. They excluded patients in whom
urine output was not possible to quantify, patients with pre-
vious urological interventions or patients on RRT. Missing
urine output data were estimated using calculating aver-
ages. AKI incidences were 69% and 52% using RIFLE and
AKIN definitions, with similar AKI incidences when adding
urine output criteria (60% with both definitions) [17].
AKI incidences in critically ill patients in retrospective
studies
Eight studies used a retrospective design to evaluate AKI
incidences. No study compared all three definitions. Seven
studies compared two definitions and one evaluated the
additive value of urine output on AKI incidences. Two
studies found AKI incidences of 36% using RIFLE defini-
tions and 26% and 37% using AKIN definitions [23, 24].
Four other studies found AKI incidences in patients with
sepsis varying from 56% to 68% depending on the defini-
tions used [25–28]. All studies used serum creatinine and
four studies also used urine output criteria. A MDRD of
75 ml/min/1.73 m2 was used as a reference value for
serum creatinine in four studies, and in three studies the
lowest serum creatinine was used. Urine output was mea-
sured as an average over 24 h in one study and not further
specified in three studies. One study analyzed the add-
itional value of urine output in AKIN definitions and
found that 12% remained unrecognized as having AKI
based on serum creatinine [14, 18].
AKI incidences in other populations
Ten studies assessed patients that were not critically ill of
which four had a prospective and six a retrospective de-
sign. Three studies with a prospective and three with a
retrospective design compared all three AKI definitions.
Incidences varied from 4 to 94%. None of the studies eval-
uated the additional value of urine output criteria.
Discussion
We have analyzed differences in AKI incidences based
on the three available definitions of RIFLE, AKIN, and
KDIGO, each with and without urine output criteria.
Urine output criteria increase AKI proportions using all
Table 3 Patient characteristics and outcome of patients grouped by the definition used to classify AKI by serum creatinine criteria




RIFLE, AKIN & KDIGO AKI
N = 212
Group 3






Age (years; mean (sd)) 63 (19) 67 (20) 68 (15) 54 (28) <0.05 (*)
Male sex (N (%)) 681 (63.1) 122 (57.5) 52 (74.3) 8 (57.1) 0.078
Body Mass Index (kg/m2; mean (sd)) 25.8 (5.6) 26.2 (5.6) 26 (6.2) 25.6 (4.7) 0.013 (****)
APACHE IV score (mean (sd)) 43 (25) 76 (30) 56 (26.5) 51.5 (36.5) 0.001 (***)
Admission type
• Medical (N (%)) 308 (28.6) 114 (53.8) 26 (37.1) 12 (85.7) 0.001
• Surgical
◦ Scheduled (N (%)) 640 (59.4) 53 (25) 32 (45.7) 2 (14.3)
◦ Emergency (N (%)) 129 (12) 45 (21.2) 12 (17.1) 0 (0)
Co morbidity
• diabetes mellitus (N (%)) 149 (13.8) 62 (29.2) 9 (12.9) 1 (7.1) 0.001
• chronic kidney disease (N (%)) 5 (0.5) 48 (22.6) 4 (5.7) 0 (0) 0.001
• chronic dialysis (N (%)) 0 (0) 23 (10.8) 1 (1.4) 0 (0) 0.001
ICU Length of stay (days; median [IQR]) 2 (2–3) 4 (2–8) 2 (2–4) 13 (4–13) 0.001 (****)
ICU mortality (N (%)) 37 (3.4) 30 (14.1) 7 (10) 3 (21.4) 0.001
Hospital mortality (N (%)) 64 (5.9) 51 (24.1) 11 (15.7) 3 (21.4) 0.001
Group 1: patients without AKI
Group 2: patients with AKI according to RIFLE, AKIN and KDIGO criteria
Group 3: patients with AKI according to AKIN and KDIGO
Group 4: patients with AKI according to AKIN
IQR interquartile range
N number of patients
APACHE IV Acute Physiology and Chronic Health Evaluation IV
ICU intensive care unit
LoS length of stay
(*) group 1 vs group 2 and 3, group 2 vs group 1 and 4, group 3 vs group 1 and 4
(***) group 2 vs group 1, 3 en 4, group 3 vs group 1 & 2
(****) group 1 vs group 2 and 4, group 3 vs group 1 and 2, group 4 vs group 1, 2 and 3
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three definitions by adding less sick patients but also en-
able quicker recognition of AKI by half a day. While RI-
FLE criteria were initially developed for uniform and
standardized reporting of outcomes, our review shows
that reported AKI incidences are far from uniform.
The RIFLE AKI definition was developed for lack of
clear definitions of AKI and to facilitate uniform report-
ing renal failure. All AKI definitions, however are vali-
dated against mortality because a gold standard for AKI
is absent. In fact, AKI criteria are prognostic factors for
mortality based on renal symptoms, but the performance
as prognostic score for mortality is mediocre [1]. Fulfill-
ing RIFLE creatinine definition requires a higher (at least
50%) creatinine rise than the absolute criterion of
26.4 μmol/l for the AKIN and KDIGO definitions and
patients will meet AKIN and KDIGO criteria more easily
(Fig. 1 and Additional file 1: Figure S1). Patients who
meet RIFLE definition will therefore be sicker as
reflected by the APACHE score and have a higher mor-
tality (Table 3). Introduction of a fixed rise in creatinine
improves sensitivity but occurs at the cost of specificity.
Adding urine output also leads to a shift in the fea-
tures of the patients identified to have AKI. A decreased
urine output may be the first signal of renal function
loss but only 20% will reach the AKI serum creatinine
criteria (Fig. 1 and Additional file 1: Table S2). Patients
only fulfilling urinary output criteria have a lower APA-
CHE IV score (Table 2). Urine output is frequently not
reported in publications for practical reasons. Our data
show that AKI incidences will rise considerably when
urine output criteria are included while patient outcome
probably improves (Table 2) which is corroborated by a
recent study [14].
Our overall AKI incidence of 15% when using serum
creatinine criteria of the RIFLE definition or 38% when
using the combination of serum creatinine and urine
output criteria of the AKIN and KDIGO definitions are
relatively low compared to the literature.
This could be explained by not having any exclusion
criterion in our study, as we included patients with less
severe illness. Two third of our patient population was
admitted less than 48 h. These design issues could have
diluted the AKI incidences. In contrast, we used baseline
serum creatinine based on an ideal creatinine using a
MDRD of 75 ml/min/1.73 m2 which could have led to
overestimation of true incidences as we scored some pa-
tients with - previously unknown - CKD as having AKI.
The choice which baseline serum creatinine is used has
an important effect on incidence of AKI and subsequent
on mortality in patients with AKI [29]. However, using
an estimated creatinine is widely accepted in studies on
AKI for determining baseline creatinine [30]. It is debat-
able whether these patients have substantial impact on
our results as our population contains only 4.2% patients
with known CKD. We had only urine output data in
1004 patients which could lead to both over and under-
estimation of AKI incidences. A possible limitation in
our urine output data is the fact that imputation was
based on averages using the first known value over the
missing hours. Unlike the study of Soliman et al., we did
not restrict our backlogging process to 6 h, which could
induce possible overestimation of AKI based on the
urine output criteria [31].
The considerations mentioned above are applicable to
most studies concerning incidence of AKI in critically ill
patients. Our presented literature review showed large
heterogeneity in patients included, AKI definition used,
reference or baseline serum creatinine used, timeframe
in which AKI was assessed and whether urine output
was used. This inclusion, definition and reference cre-
atinine heterogeneity could explain the differences in
AKI incidence in these studies and makes published
studies difficult to compare. We intended to conduct a
sensitive literature search. However, a sensitive search
strategy is always a trade-off between a sufficiently large
numbers of hits so that it can be considered sensitive
and a sufficiently low numbers of hits so that it can be
achievable. With different search criteria other studies
might also have been included.
More than a third of patients who only fulfilled AKI
criteria based on urine output were admitted after
scheduled surgery (Table 2). The significance of oliguria
only in the post-operative period is relatively unknown
Fig. 2 Proportions of patients who develop AKI according to RIFLE
definition during ICU admission. Proportions of patients who
develop AKI according to RIFLE definitions based on urine output
criteria (green line) and serum creatinine criteria (blue line) plotted
against the time in hours since admission to the ICU. Only patients
without AKI at ICU admission who developed AKI within the first
week of ICU admission are included in this graph
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and it is questionable if the prognostic value of AKI
diagnosis and classification on oliguria only is applicable
to these patients, although patients only fulfilling urine
output criteria have higher one year mortality than pa-
tients not meeting one of the AKI criteria [14, 32, 33].
The addition of urine output criteria to serum creatinine
criteria leads to higher AKI incidences with earlier rec-
ognition especially in patients with mild to moderate
AKI. It may be possible that more frequent measure-
ments of serum creatinine also reduce the time needed
for AKI detection but that would increase costs. Earlier
recognition of patients having AKI could provide possi-
bilities for prevention of kidney function deterioration
and potentially improve outcomes [34]. Furthermore, es-
pecially long-term follow up data are needed to evaluate
associations between AKI based on urine output criteria
only and kidney function and survival.
Conclusion
AKIN and KDIGO define a less ill population with a bet-
ter outcome, compared to RIFLE. Urine output criteria
detect patients with AKI 11 h earlier than serum creatin-
ine criteria and gives approximately doubling of AKI in-
cidences in critically ill patients, but most of these
patients will never reach creatinine criteria. Consensus
definitions have improved research opportunities, how-
ever the definitions used, addition of urine output cri-
teria and the patients under study all influence AKI
incidences and possibly outcomes.
Summary
The AKI definition which is used and whether serum
creatinine is combined with urine output criteria influ-
ences the AKI incidence and the AKI outcome. Adding
urine output criteria detects AKI quicker than using only
serum creatinine.
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